Dr. Earle F. Burgess
Overview
Earle Burgess is an Oncologist in Charlotte, North Carolina. Dr. Burgess is rated as an Experienced provider by MediFind in the treatment of B-Cell Lymphoma. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Chromophobe Renal Cell Carcinoma. Dr. Burgess is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1021 Morehead Medical Drive, Building 1, Suite 5300, Charlotte, NC 28204
Additional Areas of Focus
Dr. Burgess has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Atrium Health Levine Cancer Institute (Hematology)
Nilanjan Ghosh is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Ghosh is rated as an Elite provider by MediFind in the treatment of B-Cell Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ghosh is currently accepting new patients.
Atrium Health Levine Cancer Institute
Steven Park is a Hematologist and an Oncologist in Concord, North Carolina. Dr. Park is rated as a Distinguished provider by MediFind in the treatment of B-Cell Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Park is currently accepting new patients.
Novant Health Cancer Institute - Elizabeth (Hematology)
David Rizzieri is an Oncologist in Charlotte, North Carolina. Dr. Rizzieri is rated as an Elite provider by MediFind in the treatment of B-Cell Lymphoma. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Soft Tissue SarcomaDr. Burgess isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Burgess isDistinguished. Learn about Bladder Cancer.
- Chromophobe Renal Cell CarcinomaDr. Burgess isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Burgess isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Burgess isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Burgess isDistinguished. Learn about Familial Wilms Tumor 2.
- Advanced
- Burkitt LymphomaDr. Burgess isAdvanced. Learn about Burkitt Lymphoma.
- ChoriocarcinomaDr. Burgess isAdvanced. Learn about Choriocarcinoma.
- Teratoma of the MediastinumDr. Burgess isAdvanced. Learn about Teratoma of the Mediastinum.
- Testicular CancerDr. Burgess isAdvanced. Learn about Testicular Cancer.
- Experienced
- Adrenal CancerDr. Burgess isExperienced. Learn about Adrenal Cancer.
- Adult Immune ThrombocytopeniaDr. Burgess isExperienced. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung CancerDr. Burgess isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Burgess isExperienced. Learn about Anemia.
- AngiosarcomaDr. Burgess isExperienced. Learn about Angiosarcoma.
- Appendix CancerDr. Burgess isExperienced. Learn about Appendix Cancer.